Biognosys Announces Strategic Agreement with Siemens Healthineers
13.4.2021 14:15:00 EEST | Business Wire | Press release
Biognosys, a leader in next-generation proteomics solutions for drug discovery and development, announces today that it has established a strategic agreement with Siemens Healthineers, a global medical technology company, through its clinical laboratory in Berkeley, California. The agreement leverages Biognosys’ expertise in unbiased biomarker discovery technologies and solutions with Siemens Healthineers’ biomarker assay development, lab testing, and commercialization capabilities.
Oliver Rinner, PhD, CEO and founder of Biognosys states: “With this agreement we can enable our biopharmaceutical customers to use the power of our proprietary discovery proteomics solution for novel biomarker identification and bring these biomarkers into clinical applications with Siemens Healthineers’ diagnostic assay development expertise.”
Using Biognosys’ proprietary Hyper Reaction Monitoring (HRMTM) mass spectrometry technology, thousands of proteins may be quantified simultaneously from a broad range of clinical sample types. HRM enables an unmatched depth of proteome coverage with reproducible and precise quantification to identify the most promising, actionable biomarkers to support clinical decision making. This discovery proteomics solution can be applied with high throughput in large-scale studies involving thousands of samples.
The strategic agreement enables discovery of novel biomarkers via the HRM technology followed by translation into validated biomarker assays for potential clinical applications. This may include clinical trials usage and In Vitro Diagnostics development programs.
Sebastian Kronmueller, Head of Siemens Healthcare Laboratory in California, commented: “We are excited about this relationship with Biognosys because their expertise and unique biomarker discovery capabilities are very complementary to our end-to-end diagnostic solutions for our biopharmaceutical customers.”
About Biognosys
Biognosys is a leader in next-generation proteomics, dedicated to transforming life science by inventing and developing cutting-edge proteomics technology and solutions, and making them widely available for pharmaceutical and biotechnology researchers and proteomics experts. The company’s proprietary solutions provide a multi-dimensional view of protein expression, function, and structure in all major biological species and sample types. Biognosys’ unique, patented technologies utilize high-resolution mass spectrometry for the quantification of thousands of proteins across thousands of samples with industry-leading, precision, depth, and throughput. Through advanced data analytics, Biognosys translates data into actionable insights for R&D and clinical research. More information at biognosys.com.
About Siemens Healthineers
To learn more about Siemens Healthineers, please visit siemens-healthineers.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210413005039/en/
Contact information
Media Contact Biognosys
Oliver Rinner, PhD
Chief Executive Officer
Phone +41 (0) 44 738 20 40
oliver.rinner@biognosys.com
Media Contact Siemens Healthineers
Lance Longwell, MBA
Director Of Communications And Public Relations
Phone +1 (610) 883-0788
lance.longwell@siemens-healthineers.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vonage Named a Leader in the 2026 IDC MarketScape for Worldwide Communications Engagement Platforms29.4.2026 10:30:00 EEST | Press release
Vonage, a part of Ericsson (NASDAQ: ERIC), today announced that it has been positioned in the Leaders Category in the 2026 IDC MarketScape for the Worldwide Communications Engagement Platforms (CEP) sector. Vonage believes this recognition reflects Vonage's comprehensive communications platform that enables enterprises to reimagine customer and employee engagement at global scale. The IDC MarketScape: Worldwide Communications Engagement Platforms 2026 Vendor Assessment (Doc #US53542326, April 2026) provides a comprehensive assessment of select communications engagement platform (CEP) vendors, highlighting their strengths, challenges, and strategic direction to guide technology buyers in making informed decisions. Vonage believes its placement in the Leaders Category underscores the breadth and depth of its portfolio, underpinned by advanced AI capabilities. Built with enterprise businesses and developers in mind, Vonage provides the tools and flexibility to quickly build and customize
AI-driven Bot Attacks Surged 12.5x According to Thales Bad Bot Report29.4.2026 10:00:00 EEST | Press release
Thales today released the 2026 Bad Bot Report: Bad Bots in the Agentic Age, revealing a fundamental shift in how the internet operates, as AI-accelerated automation becomes a defining feature of modern digital infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260428783532/en/ ©Thales The findings highlight three major structural changes: the emergence of AI agents as a new category of internet traffic, the dominance of automated activity over human interaction, and the rapid expansion of attacks targeting APIs and identity systems that serve as the backbone of digital business. AI Is Redefining Internet Traffic and Security The report shows that AI is not just increasing the volume of bot activity, but fundamentally changing its nature. In 2025, AI-driven bot attacks surged 12.5x compared to the previous year. More significantly, AI agents are now emerging as a third category of traffic, alongside traditional “g
OpenGate Capital Signs Definitive Agreement to Acquire Total Safety’s Europe and Middle East Division29.4.2026 10:00:00 EEST | Press release
OpenGate Capital (“OpenGate”), a global private equity firm, announced today that it has signed a definitive agreement to acquire the European and the Middle Eastern (“EMEA”) division of Total Safety, a Littlejohn & Co. portfolio company. Total Safety EMEA is a leading provider of mission-critical safety and compliance solutions serving petrochemical and oil & gas customers across EMEA. The company focuses on workforce protection and regulatory compliance in complex, safety critical environments. Terms of the acquisition were not disclosed. Headquartered in Diepenbeek, Belgium, Total Safety EMEA offers a fully integrated, one-stop platform spanning safety services, rental equipment and product sales. Services include the deployment of highly trained personnel for critical safety operations, short- and long-term rental of essential equipment and the supply of personal protective equipment. As a trusted partner embedded in highly regulated environments, Total Safety EMEA supports clients
Hytera to Host Global Partner Summit 2026 in Shanghai, Advancing AI-Powered Mission-Critical Communications29.4.2026 09:00:00 EEST | Press release
Hytera Communications, a leading global provider of critical communications technologies and solutions, today announced it will host its highly anticipated Hytera Global Partner Summit (HGPS) 2026 in Shanghai on May 8, 2026, bringing together partners from more than 60 countries worldwide. Held under the theme "Advancing Together", this year’s summit marks the return of HGPS to China after several years overseas. As Hytera’s flagship event, it serves as a key platform to deepen collaboration, align strategic priorities, and unlock new opportunities for shared growth in an increasingly dynamic global market. The agenda will feature executive keynotes, new product launches, technology workshops, and partner-focused discussions, offering participants valuable insights into market trends and future development directions. A major highlight of HGPS 2026 will be the immersive exhibition pavilion, showcasing Hytera’s end-to-end portfolio and next-generation AI-powered solutions. Spanning sect
Autonomous University of Sinaloa (UAS) Releases Study on the Positive Economic Impacts of Pacifico Mexinol Project in Northern Sinaloa29.4.2026 01:39:00 EEST | Press release
As part of an ongoing joint effort between the academic and commercial sectors, stemming from a Collaboration Agreement between the Autonomous University of Sinaloa (UAS) and Pacifico Mexinol (a subsidiary of Transition Industries) signed in 2024, UAS released the findings of the economic effects study of the world's largest ultra-low-carbon methanol plant, located near Topolobampo, Ahome, Sinaloa. The Pacifico Mexinol project is aligned with the UN Sustainable Development Goals by promoting the use of clean energy, the utilization of treated wastewater, and climate change mitigation. It protects local ecosystems and will generate thousands of local jobs. The project represents more than the construction of industrial infrastructure; it is a trigger for economic growth for northern Sinaloa and Mexico. The study estimated the direct and indirect economic effects of the project’s investment in terms of employment, income, value added, and social well-being; identified regional developmen
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom